| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $152.3M | -8.7% |
| R&D Expense | $195.2M | +1.6% |
| SG&A Expense | $52.8M | -0.1% |
| Operating Income | -$95.7M | -22.3% |
| Pre-tax Income | -$80.9M | -190.2% |
| Income Tax | -$4K | -100.2% |
| Net Income | -$80.9M | -172.3% |
| EPS (Basic) | -$3.00 | -167.9% |
| EPS (Diluted) | -$3.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $237.0M | -18.8% |
| Accounts Receivable | $4.0M | -87.6% |
| Current Assets | $306.0M | -20.9% |
| Total Assets | $344.1M | -19.9% |
| Current Liabilities | $65.5M | -20.1% |
| Total Liabilities | $103.1M | -31.7% |
| Stockholders' Equity | $241.0M | -13.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.7M | -230.1% |
| Capital Expenditures | $648K | -77.7% |
| Investing Cash Flow | -$648K | +77.7% |
| Financing Cash Flow | $5.4M | +122.5% |
| Free Cash Flow | -$60.4M | -187.6% |
| -167.9% |